[Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application]

Area of Science:

• Oncology
• Sarcoma Research
• Translational Medicine

Background:

• Malignant peripheral nerve sheath tumor (MPNST) is a rare, aggressive soft tissue sarcoma originating from peripheral nerves.
• MPNST exhibits rapid progression, poor prognosis, and high mortality due to resistance to conventional therapies like radiotherapy and chemotherapy.
• Early radical surgery remains the primary effective treatment, but targeted therapies are urgently needed.

Purpose of the Study:

• To review current translational research on MPNST.
• To identify and summarize potential therapeutic targets for MPNST.
• To provide insights into clinical trials for MPNST targeted therapy.

Main Methods:

• Literature review of translational research on MPNST.
• Analysis of key molecular pathways implicated in MPNST development and progression.
• Summary of identified therapeutic targets and relevant clinical trials.

Main Results:

• Identified key molecular pathways including NF1-Ras, Raf-MEK-ERK, PI3K-AKT-mTOR, and Wnt signaling.
• Highlighted abnormal expressions of apoptotic proteins, polycomb repressive complex 2 (PRC2), HDAC family, receptor tyrosine kinases, PD-L1, aurora kinase, and microRNAs.
• Compiled information on emerging therapeutic targets and ongoing clinical trials.

Conclusions:

• MPNST research has identified numerous potential therapeutic targets.
• Targeted therapies hold promise for improving outcomes in MPNST patients.
• Further clinical investigation is crucial for developing effective MPNST treatments.